Division of Respiratory Medicine, Department of Medicine, United Christian Hospital, Hong Kong SAR, China.
Respirology. 2013 Jul;18(5):814-9. doi: 10.1111/resp.12080.
Patients with chronic obstructive pulmonary disease (COPD) presenting with acute hypercapnic respiratory failure (AHcRF) benefit from non-invasive ventilation (NIV). The best way to withdraw NIV is not known, and we conducted a pilot study comparing stepwise versus immediate withdrawal of NIV in these patients.
This was a prospective, single-centre, open-labelled randomized study comparing stepwise versus immediate withdrawal of NIV in patients with COPD exacerbation recovering from AHcRF. The primary end-point was the success rate of NIV withdrawal, defined as no restarting of NIV from randomization to 48 h after complete withdrawal of NIV.
Sixty patients were randomized, 35 patients to stepwise withdrawal and 25 patients to immediate withdrawal. The two study arms were clinically comparable. There was no statistically significant difference in the success rate, with NIV successfully stopped in 74.3% and 56% in the stepwise and immediate withdrawal groups, respectively (P = 0.139).
We could not show any benefits for either strategy to withdraw NIV. The study may have been underpowered to detect differences, and larger prospective studies are required.
伴有急性高碳酸血症性呼吸衰竭(AHcRF)的慢性阻塞性肺疾病(COPD)患者受益于无创通气(NIV)。停止使用 NIV 的最佳方法尚不清楚,我们进行了一项试点研究,比较了这些患者中逐步撤机与立即撤机的效果。
这是一项前瞻性、单中心、开放标签随机研究,比较了 COPD 加重后从 AHcRF 恢复的患者中逐步撤机与立即撤机的效果。主要终点是 NIV 撤机的成功率,定义为从随机分组到完全撤机后 48 小时内无再次启动 NIV。
共有 60 例患者被随机分配,35 例患者接受逐步撤机,25 例患者接受立即撤机。两组患者的临床特征相似。两组的成功率无统计学差异,分别为 74.3%和 56%(P=0.139)。
我们无法证明任何一种撤机策略都有优势。该研究可能因效力不足而无法检测到差异,需要更大规模的前瞻性研究。